❯ Safe Superintelligence lands $5 billion strategic investment from NVIDIA, compute to rise tenfold
[FUND FLOW] According to Bloomberg and Reuters, NVIDIA will invest $5 billion in Safe Superintelligence (SSI), the startup founded by Ilya Sutskever, with the two sides also reaching a long-term strategic partnership. SSI will get access to NVIDIA’s next-generation Vera Rubin systems, and the company says its available compute will rise roughly tenfold over the next 12 months. This is one of the largest external investments NVIDIA has made in the current AI boom. SSI was founded in June 2024, has around 50 employees, and to date has no product, no API, and no public research.
[TWO YEARS SILENT] The timeline is worth laying out clearly. From day one, SSI has done exactly one thing — Sutskever says the company’s first product is safe superintelligence, and until that exists it will ship no API and build no chatbot. In early 2026, the company raised $2 billion at a $32 billion valuation, bringing cumulative funding to about $6 billion and making it the world’s highest-valued zero-product AI lab. For the following six months, SSI kept a low profile, running mostly on Google Cloud TPUs. This pivot to NVIDIA is effectively the first declaration, after two years of silence, that it is ready to start burning compute — this is not a fundraising cadence issue, it is a signal that the research phase has switched. The last round closed only about six months ago; money is not the constraint, chips are.
[NOT EQUITY] For NVIDIA, this looks more like customer cultivation than a financial investment. Over the past two years it has repeatedly used the same playbook: invest in AI developers, then have them spend the money back on its own compute hardware — OpenAI, xAI, and CoreWeave are all in this web. What makes SSI unusual is that it has zero revenue to date, yet just received $5 billion. NVIDIA is betting on Sutskever’s technical judgment and on the logic that “if superintelligence really emerges here, the chip supplier has to be in the room.” Look at it from SSI’s side: this single partnership solves the hardest problem for an independent lab — securing compute on par with the top labs without shipping products or generating cash flow. The cost is a research roadmap tied to NVIDIA hardware.
[ZERO-PRODUCT BOUNDARY] This deal puts a question squarely on the table: a 50-person company with no revenue and no papers is worth $32 billion — what exactly is the market pricing? The answer is the scarcity of Sutskever himself. The core technical judgment behind ChatGPT came from him, and there is no second such track record in the field today. But hardware lock-in also concentrates risk — when the compute supplier is also a shareholder, the accounting optics of circular transactions will be the first thing questioned when the cycle turns. Analysts are already watching how NVIDIA consolidates and discloses this type of investment.
▪ SIGNAL What NVIDIA is buying is not SSI’s future revenue, but the ticket that guarantees it is in the room if superintelligence actually arrives.
❯ Fusion Company Commonwealth Fusion Raises Another $1 Billion, Hitting $4 Billion in Cumulative Funding
[WHO PAID] According to the company’s July 30 announcement, fusion energy company Commonwealth Fusion Systems (CFS) raised $1 billion in new equity financing, bringing cumulative funding to $4 billion, accounting for about 30% of the total capital historically raised in the global fusion industry. This is the industry’s largest single financing round since the $1.8 billion Series B in 2021. The investor structure this round is markedly different from previous rounds: pension funds, sovereign wealth funds, and infrastructure and industrial capital came in. The company says this is the first time the fusion industry has received pension money.
[FIVE YEARS] From the $1.8 billion Series B in 2021 to today, nearly five years have passed. What CFS has done in those five years is solid: at its headquarters in Devens, Massachusetts, the demonstration device SPARC is about 75% complete; the company expects first plasma in 2026 and net energy gain in 2027. Meanwhile, it has broken ground in Chesterfield County, Virginia, on ARC, the world’s first grid-scale fusion power plant. The shift in funding structure is happening precisely at this juncture — venture capital bets on “whether the technology works,” while pension and infrastructure capital bets on “whether the power plant can be built.” The change in investor type is itself an endorsement of engineering progress.
[WHY IT] There are many fusion companies, but only CFS has brought conservative money in, because it has broken uncertainty down into verifiable milestones. SPARC is not a concept machine; it is a tokamak built with high-temperature superconducting magnets, and its progress can be reported in percentages. ARC has a specific site, a specific county, and a specific grid-connection target — a narrative that is legible to infrastructure investors. By contrast, most fusion peers remain at the stage of “can it ignite in the lab?” It has rewritten a physics problem as a schedule problem — precisely what pension funds can price. The caveats remain: net energy gain has not yet been achieved, and the 2027 date is subject to future announcements.
[ENERGY FOUNDATION] This funding does not feel out of place in the context of AI investment. The electricity shortfall at data centers has moved from an industry talking point to a hard constraint. The most direct beneficiaries are technology pathways that can provide baseload power around 2030. CFS getting pension money shows that fusion has crossed the threshold of a research project and entered the pricing range of long-term infrastructure assets. The next capital to chase in will most likely go to energy companies that can also produce a schedule, rather than the ones still explaining physics.
▪ SIGNAL The moment pension funds entered, fusion’s valuation anchor shifted from research budgets to power plant depreciation.
❯ Thermal-storage company Antora raises $550M Series C, co-led by Eclipse and G2
[THE ROUND] Per a July 30 announcement, thermal-storage company Antora has closed a $550 million Series C, co-led by Eclipse and G2 Venture Partners, with proceeds earmarked for building its second factory. The follow-on roster is unusually long: Bill Gates’ Breakthrough Energy Ventures, Decarbonization Partners — the BlackRock–Temasek joint venture — Ribbit Capital, Salesforce Ventures, StepStone, Liberty Mutual Strategic Ventures, and John Doerr personally. Founded in 2017 and headquartered in San Jose, California, the company has raised $770 million in cumulative funding.
[CARBON BRICKS] Antora’s technical path hasn’t changed in nine years: solid carbon blocks store heat, turning low-cost electricity or renewable energy into high-temperature thermal energy, then releasing it as heat or electricity when needed. This route was niche in 2017 — back then, almost all storage capital flowed into lithium batteries. The turning point came over the past two years, as data center electricity demand surged, pushing two previously unrelated needs — heat for heavy industry and power for data centers — onto the same timeline. Nine years on the bench produced not a technology breakthrough but a demand-side reordering. The presence of climate funds, fintech funds, and insurance capital together among the follow-on investors shows this is no longer treated as a pure climate-technology investment.
[CARBON VS. LITHIUM] Three hard differences. First, carbon-block raw material costs are far lower than lithium’s, and they aren’t subject to battery-grade lithium salt price cycles or supply-chain geopolitical risk. Second, Antora sells a modular product that can be paired with renewables or plugged directly into the grid — deployment is more flexible than centralized power plants. Third, heavy industry fundamentally needs high-temperature heat, while lithium batteries only produce electricity; converting it back to heat incurs an extra loss. Antora is the native solution in this scenario, not a substitute. The destination of this round’s capital is equally blunt: not R&D, but a second factory. The company is past the technology-proving stage; the bottleneck now is capacity.
[REORDERED] The Antora round shows the investment logic on the power side is stratifying: on one side are decade-long baseload-power bets like CFS; on the other are capacity-type assets like Antora that can be delivered within three to five years and directly ease today’s power shortages. The latter more readily attracts insurance and industrial capital, because the return cycle lines up with manufacturing’s standard depreciation schedules. Under pressure are storage technologies without a path to mass production — once capital starts paying for factories rather than patents, lab-stage companies will find fundraising markedly harder.
▪ SIGNAL From backing technology to backing factories, the valuation anchor in the storage sector has shifted to the capacity ramp-up curve.
❯ Nuclear Microreactor Firm Antares Raises $470M in Paradigm-Led Round Targeting Military Orders
[CAPITAL & STRUCTURE] According to a July 27 announcement, nuclear fission company Antares closed a $470 million Series C, led by Paradigm and Caffeinated Capital, with $370 million in equity and $100 million in debt. The company develops compact nuclear microreactors for defense and space applications, with power output ranging from 100 kW to 1 MW. It is one of three finalists in the U.S. Department of Defense’s advanced nuclear program, plans to deploy its first reactor next year, and will begin deliveries at U.S. military bases starting in 2028. Cumulative funding stands at $604 million.
[EIGHT MONTHS] The timing is sharp: Antares’ previous round was a $96 million Series B in December 2025, just about eight months ago, and this round is nearly five times that amount. The company was founded three years ago. Only one key change happened in between — being shortlisted for the DoD program. That turned the company from “a startup building small reactors” into “one of three candidate suppliers,” changing the nature of the risk: no longer whether the technology can be built, but whether it can be delivered on the military’s timeline. Debt accounting for more than 20% of this round sends the same signal — when the revenue source is a government contract, debt investors dare to step in. Venture capital prices possibility; debt prices contracts.
[WHY IT] Antares uses TRISO fuel, in which fuel particles are encased in multi-layer ceramic shells that resist melting at high temperatures — a critical safety prerequisite in mobile and forward-deployed scenarios. The power range is deliberately kept low — 100 kW to 1 MW — not chasing generation economics, but solving one specific problem: “how front-line bases and space missions can break free of diesel supply lines.” This is its fundamental divide from mainstream small modular reactor companies: others compete against grid-level cost per kilowatt-hour, it competes against diesel truck fleets, whose cost baseline is an order of magnitude higher, making the commercial loop far easier to close. Lead investor Paradigm has long favored frontier hard tech; this time it is betting on the certainty of defense procurement.
[DEFENSE AS BUYER] This round reveals a shortcut to nuclear commercialization: bypass grid regulation and cost-per-kilowatt-hour competition, and sell first to customers who are insensitive to price and extremely sensitive to reliability. Among energy startups, the first to benefit are those able to win defense orders; the first to feel pressure are peers betting on civilian grids and competing on cost against solar-plus-storage. What’s worth watching next is whether the 2028 batch of base deliveries materializes — military orders can prop up valuations, but once eliminated or delayed, alternative buyers are virtually nonexistent.
▪ SIGNAL The moment debt capital came in, Antares’ risk profile shifted from technological uncertainty to delivery performance.
❯ AI simulation company Simile raises $200M at $2B post-money, just five months after last round
[LEAP] According to a July 30 announcement, AI simulation company Simile closed a Series B of more than $200M, with a $2B post-money valuation, led by Greenoaks, with Index Ventures, Bain Capital Ventures, CVS Health Ventures and others participating. The company builds synthetic users — using AI to simulate how real populations behave and respond, replacing traditional focus groups and user research. Headquartered in Palo Alto, California, it now has more than 50 employees.
[TIMELINE] The timeline is the most striking thing about this deal. In February 2026, Simile had just come out of stealth with a $100M Series A led by Index Ventures; five months later, it’s valued at $2B. In between, the company released no new-generation model — the change is entirely on the customer side: CVS Health, Deloitte, and Gallup have all onboarded, using the platform for new-product launch simulations, customer experience optimization, and new-market entry testing. Especially worth noting: CVS Health Ventures went from customer to shareholder — the hardest kind of endorsement to secure in a services business like market research. Reaching $2B just five months after product launch shows this round was chased by investors, not raised because the company needed the money.
[WHY] The cost structure of traditional focus groups sets its ceiling: a single study takes weeks and a few dozen people — small sample, long cycle, impossible to repeat. Simile replaces this with simulations that can be run on demand, tuned on the fly, and reproduced at will — essentially turning user research from a one-time purchase into a software call. The fact that Gallup, a company whose core business is polling, is willing to plug in is a very strong signal — even institutions whose stock-in-trade is population samples are handing part of the work to simulation. Its moat is not the model itself, but the real-world cases it has already locked in across healthcare, finance, and consulting — three highly regulated, high-ticket industries. What later entrants have to replicate is this set of reference customers, not the technology.
[BUDGET] In this week’s eight funding rounds, Simile is the only high-valuation company with no assets beyond software — its pricing logic is the exact opposite of the energy deals: it doesn’t depend on construction schedules, it depends on replacing an existing line item in corporate budgets. Global annual market-research spending is sitting right there; what investors are buying is the possibility of migrating that budget into software. The next thing to watch isn’t its customer count, but the renewal rate — whether synthetic users are still being treated as a basis for decisions a year from now determines whether that $2B is realized or walked back.
▪ SIGNAL What’s actually being priced is not simulation accuracy — it’s the migration speed of that annual market-research budget.
❯ Chip Interconnect Company Eliyan Closes $145M Series C, Valuation Reaches $1B
[INVESTORS] According to a July 29 announcement, chip interconnect company Eliyan closed a $145 million Series C at a valuation of $1 billion, officially attaining unicorn status. Seligman Ventures led the round, with Cisco’s investment arm and optical communications maker Lumentum entering as new strategic investors. The company is based in Santa Clara, California, was founded in 2021, and has cumulative funding of approximately $295 million. This round will fund expansion from its existing electrical chiplet interconnect business into electro-optical interconnect for AI systems.
[INVESTOR SHIFT] Timeline: a $40 million Series A in November 2022, a $60 million Series B in March 2024, and a $50 million strategic round in January 2026 — the strategic round’s investors were AMD, Arm, Coherent, and Meta. Six months ago, the incoming investors were chip designers and hyperscalers; this round, they are Cisco and Lumentum — network equipment and optical module vendors. This reshuffling of the investor roster speaks louder than the amounts themselves: Eliyan’s business boundary is expanding from “how two dies inside a package communicate” to “how racks communicate with each other.” When upstream and downstream players in the industry chain take turns investing, it usually means the technology has entered their roadmaps.
[EDGE] Founded by Ramin Farjadrad, Patrick Soheili, and Syrus Ziai, Eliyan’s business model is licensing technology to chip manufacturers rather than making chips itself — which lets it be accepted by both AMD and Meta without creating competitive conflict. The key technical difference: NuLink uses standard packaging to deliver high-speed die-to-die, chip-to-chip, and even rack-to-rack communication, without relying on expensive advanced packaging processes. With advanced packaging capacity under long-term strain, this directly determines customers’ production viability. The bottleneck of AI clusters has shifted from single-card compute to data movement between chips — and that is exactly where Eliyan sits.
[DATA MOVEMENT] Among the eight deals in this issue, this round ranks second smallest in size, yet its signal is substantial: investors are starting to pay for the space between compute rather than compute itself. Interconnect, optical modules, and memory expansion — once treated as supporting components — are turning from cost items into bottleneck items, and valuation logic is being rewritten accordingly. The next capital to chase in will most likely move along this chain toward optics — Cisco and Lumentum appearing simultaneously on the shareholder roster has already marked the direction.
▪ SIGNAL AI’s bottleneck has moved from inside the chip to between chips, and capital’s attention has followed.
❯ Corporate payments company PEX secures $160M in equity and debt financing, led by Bluff Point
[EQUITY + DEBT] According to a July 28 announcement, corporate payments platform PEX has closed a $160 million equity-and-debt hybrid round, led by private equity firm Bluff Point Associates, with Clear Haven Capital Management providing a credit facility to support its credit card business. Headquartered in New York and founded in 2007, the company offers prepaid cards, credit cards, disbursement cards, and virtual cards, along with spend controls, AI receipt recognition, and automated approval workflows. The platform has processed more than $11.7 billion in spending to date.
[19 YEARS IN] The timing angle is especially important here: PEX is not a startup — it was founded 19 years ago, and for most of that time it has grown off its own operations, rarely raising major external capital. It chose to raise a large round at this point, and the direct reason for “why now” is triple-digit growth in the credit card business over the past few quarters — as it expanded from prepaid cards (customers load funds first) to credit cards (PEX fronts the funds), the business shifted from software to credit, and credit needs capital firepower. That also explains why this round is equity plus debt rather than pure equity: funding a growing advance book is cheaper with debt and less dilutive. Clear Haven is providing a dedicated credit facility, not venture debt in the usual sense. The other two uses of proceeds are expanding the sales team and continuing to build AI capabilities.
[WHY PEX] Compared with the expense-management software entrants of recent years, PEX’s edge is not the product — it’s that it holds both card issuance and software. Most peers either build only the software and rely on a third party for the card, or issue cards without a workflow. Only by combining both ends can PEX deliver the closed loop of “front the funds, auto-collect the receipts, then enforce budget rules.” Its $11.7 billion in cumulative processing volume provides another thing latecomers cannot get in the short term: the historical data needed for credit decisions. Lead investor Bluff Point is a private-equity firm focused on growth-stage financial services and technology companies — what it’s backing is clearly not disruption, but a cash-flow business that has already proven itself and just needs capital to scale.
[AI & MARGIN] This PEX raise is completely different in character from the other seven deals in this briefing: no valuation disclosed, no frontier technology, no ten-year narrative — only a growth rate and processing volume. In its model, AI is not a product selling point; it’s the means of pushing down the labor cost of receipt processing and thereby widening the gross margin of the credit business. Deals like this benefit from the current bifurcation of the private market — when capital chases both high-uncertainty frontier bets and steady cash flows, the companies in the middle have the hardest time raising. Going forward, growth-stage private equity will keep scanning mature fintech for assets that can be levered with debt.
▪ SIGNAL This is a credit business adding leverage after using AI to push down unit costs — not AI fundraising in the usual sense.
❯ Smart-Toilet Company Throne Science Raises $10 Million, Former Whoop Co-Founder Involved
[SMALL MONEY] According to a July 28 announcement, health-hardware company Throne Science closed a $10 million Series A, led by Will Ventures, with participation from Emerson Collective, Accomplice, Moxxie Ventures, and others, bringing cumulative funding to nearly $18 million. The product is a sensor that mounts on a standard toilet and uses computer vision to analyze elimination data, giving users long-term insight into digestive health, hydration status, and urinary function. The company was founded in 2023.
[THREE-YEAR CLIMB] Timeline: founded in 2023, raised a $4 million seed round in May 2025, and closed its Series A in July 2026 — not a fast cadence, because the first hurdle was not technology but acceptance. The three founders are CEO Scott Hickle, CTO Tim Blumberg, and John Capodilupo, former CTO of fitness-band company Whoop. Capodilupo himself has ulcerative colitis — which explains why this company exists. In the 14 months between seed and Series A, the more critical shift was in the industry itself: sleep, heart rate, and blood oxygen have been fully mined, so growth has to chase new data sources.
[WHY THIS ONE] Throne occupies a spot no wearable can reach: bands can’t measure the gut. And gut health is precisely the slice of the consumer-health market where demand is real but objective data is almost zero — right now, the best users can do is fill out questionnaires themselves. Throne uses visual recognition to turn that into continuous readings generated automatically every day, requiring no user effort, and an AI coach then correlates diet, daily routine, and gut status. Capodilupo’s value goes beyond endorsement: Whoop’s core capability was never the sensor — it was turning continuous readings into recommendations users actually want to see every day, and that methodology carries over directly. The hardware mounts on a standard toilet, no bathroom remodeling required, and the customer-acquisition barrier is kept to a minimum.
[NEXT DATA] At $10 million, this is the smallest deal in this batch, but it marks a direction: competition in consumer health hardware has shifted from measuring accurately to measuring what hasn’t been measured. Once wrist metrics are commoditized, the first company to capture a brand-new class of continuous data gets the first shot at the training material for the next generation of health models. The real test for these companies isn’t fundraising — it’s retention. Only if users keep the device on their toilet long-term does the data asset become real. If active usage holds up a year from now, the first thing to be revalued will be non-wearable health monitoring as a whole.
▪ SIGNAL Wearables have exhausted the wrist; the next round of competition is about who finds the class of continuous data that hasn’t been captured yet.
OUTLOOK
[DIVIDING LINE] The eight deals total roughly $7.7 billion, with $6.9 billion landing at the two extremes. CFS got pension money, Antares got defense orders, Antora got factory capacity — the common thread is that all converted uncertainty into timelines and contracts. The exception is PEX — it secured a debt-equity hybrid on the strength of a credit business that has proven itself, which shows the middle ground hasn’t disappeared; the bar has just been raised. The winners are companies that can produce a timeline and predictable cash flow; the ones under pressure are mid-tier players with only patents and no customers yet. If the 2027 power gap turns out less tight than expected, the premium paid for timelines will be the first to ease. Next, keep an eye on renewal and repurchase data from companies like Simile and PEX.